Kin-cohort evaluation of relative risks of genetic variants

Genetic Epidemiology

Volumn 24, Issue 3, 2003, Pages 220-229

  Saunders, Catherine L ^a   Begg, Colin B ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Case control studies; Epidemiologic methods; Genetics; Risk; Risk factors

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER FAMILY; CASE CONTROL STUDY; COHORT ANALYSIS; GENETIC EPIDEMIOLOGY; HUMAN; RISK ASSESSMENT; RISK FACTOR;

CASE-CONTROL STUDIES; COHORT STUDIES; EPIDEMIOLOGIC METHODS; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASMS; RISK FACTORS; VARIATION (GENETICS);

EID: 0037388774     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.10235     Document Type: Article

References (37)

1. Aalen OO. 1991. Modelling the influence of risk factors on familial aggregation of disease. Biometrics 47:933-45.
2. Anglian Breast Cancer Study Group. 2000. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-8.
3. Antoniou AC, Gayther SA, Stratton JF, Ponder BAJ, Easton DF. 2000. Risk models for familial ovarian and breast cancer. Genet Epidemiol 18:173-90.
4. Begg CB. 2002. On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221-6.
5. Bishop DT, Williamson JA. 1990. The power of identity-by-state methods for linkage analysis. Am J Hum Genet 46:254-65.
6. Brown BW, Lovato J, Russell K. 1999. Asymptotic power calculations: description, examples, computer code. Stat Med 18:3137-51.
7. Chatterjee N, Wacholder S. 2001. A marginal approach for estimating penetrance from kin-cohort designs. Biometrics 57:245-52.
8. Chatterjee N, Shih J, Hartge P, Brody L, Tucker M, Wacholder S. 2001. Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study. Genet Epidemiol 21:123-38.
9. Frayling IM, Beck NE, Ilyas M, Dove-Edwin I, Goodman P, Pack K, Bell JA, Williams CB, Hodgson SV, Thomas HJW, Talbot IC, Bodmer WF, Tomlinson IPM. 1998. The APC variants 11307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci USA 95:10722-7.
10. Fusaro RM. 2001. The validation of medical histories in kindreds. Arch Dermatol 137:506-7.
11. Gail MH, Pee D, Benichou J, Carroll R. 1999. Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs. Genet Epidemiol 16:15-39.
12. Hopper JL, Carlin JB. 1992. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol 136:1138-47.
13. Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MRE, et al. 1999. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol Biomarkers Prev 8:741-7.
14. Hopper JL, Chenevix-Trench G, Jolley DJ, Dite GS, Jenkins MA, Venter DJ, et al. 1999. Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Cooperative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 26:95-100.
15. Houlston RS, Tomlinson IP. 2001. Polymorphisms and colorectal tumor risk. Gastroenterology 121:282-301.
16. Lange K. 1986. The affected sib-pair method using identity by state relations. Am J Hum Genet 39:148-50.
17. Li H, Yang P, Schwartz AG. 1998. Analysis of age of onset data from case-control family studies. Biometrics 54:1030-9.
18. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. 2000. Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85.
19. Mack TA, Hamilton AS, Press MF, Diep A, Rappaport B. 2002. Heritable breast cancer in twins. Br J Cancer 87:294-300.
20. Pasquini P. 1999. Does assessment of family history of melanoma provide valid information? Arch Dermatol 135:1527-8.
21. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BD, editors. 1973-1999. SEER cancer statistics review, 1973-1999. Bethesda, MD: National Cancer Institute. [http://seer.cancer.gov/csr/1973_1999/,2002.]
22. Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, et al. 2001. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700-10.
23. Risch N. 1990. Linkage strategies for genetically complex traits: I. Multilocus models. Am J Hum Genet 46:222-8.
24. Rothman KJ, Greenland S. 1998. Modern epidemiology. Philadelphia: Lippincott-Raven. p 98-9.
25. Rybicki BA, Elston RC. 2000. The relationship between the sibling recurrence-risk ratio and the genotype relative risk. Am J Hum Genet 66:593-604.
26. Self SG, Mauritsen RH, Ohara J. 1992. Power calculations for likelihood ratio tests in generalized linear models. Biometrics 48:31-9.
27. Shih JH, Chatterjee N. 2002. Analysis of survival data from case-control family studies. Biometrics 58:502-9.
28. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, et al. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-8.
29. Thomas DC, Witte JS. 2002. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11:505-12.
30. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, et al. 1999. Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337-9.
31. Wacholder S, Hartge P, Struewing JP, Pee D, McAdams M, Brody L, et al. 1998. The kin-cohort study for estimating penetrance. Am J Epidemiol 148:623-30.
32. Wacholder S, Rothman N, Caparaso N. 2002. Validity of conclusions from epidemiologic studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev 11:513-20.
33. Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, et al. 1999. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241-7.
34. Weinstock MA, Brodsky GL. 1998. Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study. J Clin Epidemiol 51:1299-1303.
35. Whittemore AS. 1995. Logistic regression of family data from case-control studies. Biometrika 82:57-67.
36. Woodage T, King SM, Wacholder S, Hartge P, Struewing JP, McAdams M, Laken SJ, Tucker MA, Brody LC. 1998. The APC 11307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 20:62-5.
37. Zhao LP, Hsu L, Davidov O, Potter J, Elston RC, Prentice RL. 1997. Population-based family study designs: an interdisciplinary research framework for genetic epidemiology. Genet Epidemiology 14:365-88.